Aldeyra Therapeutics

Aldeyra Therapeutics is located in Lexington, United States on 131 Hartwell Ave. Aldeyra Therapeutics is rated 5 out of 5 in the category biotechnology company in United States. Aldeyra Therapeutics (Nasdaq: ALDX) is a biotechnology company devoted to developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated diseases. Aldeyra's lead investigational drug product candidates are first-in-class potential treatments in development for dry eye disease, allergic conjunctivitis, proliferative vitreoretinopathy, and Sjögren-Larsson Syndrome. The company is also developing other product candidates for retinal and systemic inflammatory diseases.